ANN FINANCIAL STATEMENTS

Ansell Ltd — balance sheet, income statement and cash flow trends

ANNAnsell Ltd

🇦🇺 Australia · AU · Healthcare · Medical Instruments & Supplies

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q2 2025 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue2.1 B $+28.7%

Gross Profit866.2 M $+42.1%

Operating Income232.1 M $+47.9%

EBITDA313.9 M $+31.3%

Net Income138.7 M $+33.7%

Peer Comparison· Medical Instruments & Supplies

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
ANN	11.4%	41.9%	15.2%	6.7%
XRAY	-1.0%	48.9%	-3.5%	-17.1%
LMAT	13.3%	72.4%	37.6%	24.3%
PLSE	-69.9%	-91.1%	-9,866.7%	-9,929.0%
ATRC	15.0%	75.5%	4.5%	-0.8%
STAA	4.0%	76.4%	-1.4%	-7.2%
Industry median	6.4%	53.7%	13.8%	3.9%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q2 2025

Equity2 B $60%
Current Liabilities469.2 M $14%
Long-term Liabilities854.5 M $26%

Key Figures

YoY change

Total Assets3.3 B $+31.8%

Total Liabilities1.3 B $+40.7%

Total Equity2 B $+25.8%

Cash & ST Investments254.2 M $+53.9%

Total Debt912.8 M $+80.7%

Net Debt658.6 M $+93.7%

Peer Comparison· Medical Instruments & Supplies

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
ANN	2.36	46.2%	2.10	59.3%
XRAY	1.53	176.9%	-16.86	25.2%
LMAT	14.32	46.7%	-1.84	64.6%
PLSE	7.26	10.8%	0.83	81.2%
ATRC	4.29	15.2%	-2.88	76.4%
STAA	5.12	10.6%	30.83	78.1%
Industry median	2.40	34.8%	1.44	62.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q2 2025 · TTM

Key Figures

YoY change

Operating Cash Flow240.7 M $+7.0%

Capital Expenditures70 M $-3.1%

Free Cash Flow170.7 M $+2.3%

Dividends Paid-73.9 M $-229.4%

Peer Comparison· Medical Instruments & Supplies

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
ANN	11.7%	8.3%	3.4%	173.5%
XRAY	7.3%	2.8%	4.5%	-42.7%
LMAT	34.1%	30.9%	3.2%	139.9%
PLSE	-7,349.7%	-7,390.0%	40.3%	74.0%
ATRC	11.7%	9.7%	3.2%	-1,401.3%
STAA	-17.3%	-18.9%	1.7%	238.7%
Industry median	13.8%	8.6%	3.8%	128.3%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ANN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 8, 26. This content is for informational purposes only and is not investment advice.